 |
|
|
Sulfanilamide
|
|
| Systematic (IUPAC) name | |
| 4-aminobenzenesulfonamide | |
| Identifiers | |
| CAS number | |
| ATC code | J01 D06 QJ01 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C6H8N2O2S |
| Mol. mass | 172.20 g/mol |
| Physical data | |
| Density | 1.08 g/cm³ |
| Melt. point | 165 °C (329 °F) |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Sulfanilamide is a sulfonamide antibacterial. Chemically, it is a molecule containing the sulfonamide functional group attached to an aniline.
The term "sulfanilamides" is also used to describe a family of molecules containing these functional groups. Examples include:
Gerhard Domagk and Jacques and Therese Trefouel (1935) are generally credited with the discovery of sulfanilamide as a chemotherapeutic agent. Domagk was awarded the Nobel Prize for his work.
See also
External links
|
|||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
This chemistry article is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)
